Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing
Cells · 2024
DOI: 10.3390/cells13100824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Halla Elshwekh und 9 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: Exons, BRCA1 Protein, RNA Precursors, RNA Splicing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian MAECI/DGCS.
Abstract (Originalsprache)
Our study focused on assessing the effects of three newly identified BRCA1 exon 11 variants (c.1019T>C, c.2363T>G, and c.3192T>C) on breast cancer susceptibility. Using computational predictions and experimental splicing assays, we evaluated their potential as pathogenic mutations. Our in silico analyses suggested that the c.2363T>G and c.3192T>C variants could impact both splicing and protein function, resulting in the V340A and V788G mutations, respectively. We further examined their splicing effects using minigene assays in MCF7 and SKBR3 breast cancer cell lines. Interestingly, we found that the c.2363T>G variant significantly altered splicing patterns in MCF7 cells but not in SKBR3 cells. This finding suggests a potential influence of cellular context on the variant’s effects. While attempts to correlate in silico predictions with RNA binding factors were inconclusive, this observation underscores the complexity of splicing regulation. Splicing is governed by various factors, including cellular contexts and protein interactions, making it challenging to predict outcomes accurately. Further research is needed to fully understand the functional consequences of the c.2363T>G variant in breast cancer pathogenesis. Integrating computational predictions with experimental data will provide valuable insights into the role of alternative splicing regulation in different breast cancer types and stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy.
- Department of Genetic Engineering, Libyan Biotechnology Research Center, Tripoli P.O. Box 30313, Libya.
- Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
- Department of Life Sciences, University of Trieste, Via A. Valerio, 28, 34127 Trieste, Italy.
ORCID-Profile: Halla Elshwekh, Ilenia Marino, Emanuele Buratti, Maurizio Romano
Förderung
- Italian MAECI/DGCS
Zitieren
APA
Elshwekh, H., Alhudiri, I. M., Elzagheid, A., Enattah, N., Abbassi, Y., Abou Assali, L., Marino, I., Stuani, C., Buratti, E., & Romano, M. (2024). Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing. Cells. https://doi.org/10.3390/cells13100824
Vancouver
Elshwekh H, Alhudiri IM, Elzagheid A, Enattah N, Abbassi Y, Abou Assali L, et al. Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing. Cells. 2024. doi:10.3390/cells13100824
BibTeX
@article{Elshwekh2024,
author = {Elshwekh, Halla and Alhudiri, Inas M and Elzagheid, Adam and Enattah, Nabil and Abbassi, Yasmine and Abou Assali, Lubna and Marino, Ilenia and Stuani, Cristiana and Buratti, Emanuele and Romano, Maurizio},
title = {Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13100824}
}
EUVIMED